Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_assertion type Assertion NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_head.
- NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_assertion description "[Our study has implications for miR-375 as a potential target in combination with trastuzumab for treating HER2-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_provenance.
- NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_assertion evidence source_evidence_literature NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_provenance.
- NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_assertion SIO_000772 24571711 NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_provenance.
- NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_assertion wasDerivedFrom befree-2016 NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_provenance.
- NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_assertion wasGeneratedBy ECO_0000203 NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_provenance.